204 related articles for article (PubMed ID: 28188442)
21. Genotype-Phenotype Correlation in Fibrous Dysplasia/McCune-Albright Syndrome.
Zhadina M; Roszko KL; Geels RES; de Castro LF; Collins MT; Boyce AM
J Clin Endocrinol Metab; 2021 Apr; 106(5):1482-1490. PubMed ID: 33512531
[TBL] [Abstract][Full Text] [Related]
22. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
Jung AJ; Soskin S; Paris F; Lipsker D
Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
[TBL] [Abstract][Full Text] [Related]
23. Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing.
Narumi S; Matsuo K; Ishii T; Tanahashi Y; Hasegawa T
PLoS One; 2013; 8(3):e60525. PubMed ID: 23536913
[TBL] [Abstract][Full Text] [Related]
24. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
25. McCune Albright syndrome and bilateral adrenal hyperplasia: the GNAS mutation may only be present in adrenal tissue.
Angelousi A; Fencl F; Faucz FR; Malikova J; Sumnik Z; Lebl J; Stratakis CA
Hormones (Athens); 2015; 14(3):447-50. PubMed ID: 26188235
[TBL] [Abstract][Full Text] [Related]
26. Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.
Hartley I; Zhadina M; Collins MT; Boyce AM
Calcif Tissue Int; 2019 May; 104(5):517-529. PubMed ID: 31037426
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
Spencer T; Pan KS; Collins MT; Boyce AM
Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
[TBL] [Abstract][Full Text] [Related]
28. Brain and eye involvement in McCune-Albright Syndrome: clinical and translational insights.
Mascioli I; Iapadre G; Ingrosso D; Donato GD; Giannini C; Salpietro V; Chiarelli F; Farello G
Front Endocrinol (Lausanne); 2023; 14():1092252. PubMed ID: 37274327
[TBL] [Abstract][Full Text] [Related]
29. Identification of GNAS Variants in Circulating Cell-Free DNA from Patients with Fibrous Dysplasia/McCune Albright Syndrome.
Roszko KL; Guthrie L; Li X; Collins MT; de Castro LF; Boyce AM
J Bone Miner Res; 2023 Mar; 38(3):443-450. PubMed ID: 36593655
[TBL] [Abstract][Full Text] [Related]
30. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
[TBL] [Abstract][Full Text] [Related]
31. McCune-Albright syndrome and disorders due to activating mutations of GNAS1.
Diaz A; Danon M; Crawford J
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):853-80. PubMed ID: 17937059
[TBL] [Abstract][Full Text] [Related]
32. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
33. Genetics of McCune-Albright syndrome.
de Sanctis L; Delmastro L; Russo MC; Matarazzo P; Lala R; de Sanctis C
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():577-82. PubMed ID: 16789620
[TBL] [Abstract][Full Text] [Related]
34. A novel technique based on a PNA hybridization probe and FRET principle for quantification of mutant genotype in fibrous dysplasia/McCune-Albright syndrome.
Karadag A; Riminucci M; Bianco P; Cherman N; Kuznetsov SA; Nguyen N; Collins MT; Robey PG; Fisher LW
Nucleic Acids Res; 2004 Apr; 32(7):e63. PubMed ID: 15096559
[TBL] [Abstract][Full Text] [Related]
35. GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation.
Nault JC; Fabre M; Couchy G; Pilati C; Jeannot E; Tran Van Nhieu J; Saint-Paul MC; De Muret A; Redon MJ; Buffet C; Salenave S; Balabaud C; Prevot S; Labrune P; Bioulac-Sage P; Scoazec JY; Chanson P; Zucman-Rossi J
J Hepatol; 2012 Jan; 56(1):184-91. PubMed ID: 21835143
[TBL] [Abstract][Full Text] [Related]
36. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.
Lumbroso S; Paris F; Sultan C;
J Clin Endocrinol Metab; 2004 May; 89(5):2107-13. PubMed ID: 15126527
[TBL] [Abstract][Full Text] [Related]
37. Searching for somatic mutations in McCune-Albright syndrome: a comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples.
Kalfa N; Philibert P; Audran F; Ecochard A; Hannon T; Lumbroso S; Sultan C
Eur J Endocrinol; 2006 Dec; 155(6):839-43. PubMed ID: 17132753
[TBL] [Abstract][Full Text] [Related]
38. [The activating GNAS mutation : A survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions].
Ostertag H; Glombitza S
Pathologe; 2018 Mar; 39(2):146-153. PubMed ID: 29488004
[TBL] [Abstract][Full Text] [Related]
39. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
Shin SJ; Lee SJ; Kim SK
Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
[TBL] [Abstract][Full Text] [Related]
40. A Novel GNAS Mutation Causing Isolated Infantile Cushing's Syndrome.
Dejkhamron P; Ittiwut C; TangNgam H; Sunkonkit K; Natesirinilkul R; Suphapeetiporn K; Shotelersuk V
Horm Res Paediatr; 2019; 92(3):196-202. PubMed ID: 31362300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
